Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
ProShares Short Bitcoin Strategy ETF
BITI
$72.6M
| $1.57M | ﹤0.01% |
+23,860
| New | +$1.57M |
|
2102
Tenaya Therapeutics
TNYA
$205M
| $1.56M | ﹤0.01% |
482,325
+48,725
| +11% | +$158K |
|
2103
First Trust Smith Unconstrained Bond ETF
UCON
$2.98B
| $1.56M | ﹤0.01% |
+63,100
| New | +$1.56M |
|
2104
FTAI Infrastructure
FIP
$560M
| $1.56M | ﹤0.01% |
400,900
+91,600
| +30% | +$356K |
|
2105
iShares Global Tech ETF
IXN
$6.06B
| $1.55M | ﹤0.01% |
22,746
+11,646
| +105% | +$794K |
|
|
LIAN
2106
DELISTED
LianBio American Depositary Shares
LIAN
| $1.55M | ﹤0.01% |
346,000
+63,398
| +22% | +$283K |
|
2107
Voyager Therapeutics
VYGR
$236M
| $1.55M | ﹤0.01% |
183,100
-220,500
| -55% | -$1.86M |
|
|
EGRX
2108
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.54M | ﹤0.01% |
294,450
+38,298
| +15% | +$200K |
|
2109
AGF US Market Neutral Anti-Beta Fund
BTAL
$372M
| $1.54M | ﹤0.01% |
+90,773
| New | +$1.54M |
|
2110
Dimensional US Equity ETF
DFUS
$16.9B
| $1.54M | ﹤0.01% |
29,700
+18,500
| +165% | +$959K |
|
2111
Backblaze
BLZE
$539M
| $1.54M | ﹤0.01% |
202,616
+79,000
| +64% | +$600K |
|
2112
Rocky Mountain Chocolate Factory
RMCF
$14.3M
| $1.54M | ﹤0.01% |
334,324
-5,639
| -2% | -$25.9K |
|
2113
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$7.74B
| $1.53M | ﹤0.01% |
+56,507
| New | +$1.53M |
|
2114
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
$1.21B
| $1.53M | ﹤0.01% |
+18,100
| New | +$1.53M |
|
2115
iShares Russell Top 200 ETF
IWL
$1.84B
| $1.53M | ﹤0.01% |
13,300
+6,400
| +93% | +$737K |
|
|
LX
2116
LexinFintech Holdings
LX
$956M
| $1.53M | ﹤0.01% |
830,800
+357,126
| +75% | +$657K |
|
2117
ATS Corp
ATS
$2.7B
| $1.53M | ﹤0.01% |
35,300
-54,400
| -61% | -$2.35M |
|
2118
Establishment Labs
ESTA
$1.13B
| $1.53M | ﹤0.01% |
+58,934
| New | +$1.53M |
|
|
FLG
2119
Flagstar Financial, Inc.
FLG
$5.03B
| $1.53M | ﹤0.01% |
+49,729
| New | +$1.53M |
|
2120
Burford Capital
BUR
$2.81B
| $1.52M | ﹤0.01% |
97,600
+65,100
| +200% | +$1.02M |
|
|
LENZ
2121
LENZ Therapeutics
LENZ
$1.18B
| $1.52M | ﹤0.01% |
83,022
+45,251
| +120% | +$830K |
|
2122
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$807M
| $1.52M | ﹤0.01% |
34,550
+18,050
| +109% | +$795K |
|
2123
Omnicell
OMCL
$1.48B
| $1.52M | ﹤0.01% |
40,400
-177,443
| -81% | -$6.68M |
|
2124
NovoCure
NVCR
$1.42B
| $1.51M | ﹤0.01% |
+101,375
| New | +$1.51M |
|
2125
World Acceptance Corp
WRLD
$916M
| $1.51M | ﹤0.01% |
11,600
+6,600
| +132% | +$861K |
|